Clinicn Investigator, Asst Prf Cancer Center, Mass General Research Institute

Assistant Professor of Medicine Harvard Medical School

Physician Medicine-Hematology and Medical Oncology, Massachusetts General Hospital

MD Albert Einstein College of Medicine 2001

PhD Albert Einstein College of Medicine 2001

anilides; biomarkers in prostate cancer; bone neoplasms; cabozantinib; circulating tumor cells; osteoblasts; osteoclasts; prostate cancer; prostatic neoplasms; proto-oncogene proteins c-met; rank ligand; receptors vascular endothelial growth factor; renal cell carcinoma Since joining the staff at MGH, Dr. Lee has been engaged in translational studies of circulating tumor cells (CTCs) from peripheral blood, using a new technology developed at MGH. Our hope is that this "CTC-Chip" may have clinical usefulness for cancer patients. In addition to seeing patients, Dr. Lee is also interested in clinical trials of new drugs to treat genitourinary cancers.